An adaptive seamless phase II/III design for oncology trials with subpopulation selection using correlated survival endpoints†
Year: 2010
Type: article
Source: Pharmaceutical Statistics
DOI: 10.1002/pst.472
Institutions: AstraZeneca (United Kingdom), University of Bath
Language: English
Subfield: Statistics and Probability
Field: Mathematics
Domain: Physical Sciences
Open Access status: closed
OpenAlex ID: W2127182852
